Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells

PURPOSE: T-DM1 is an antibody–drug conjugate (ADC) consisting of trastuzumab and DM1 linked together. T-DM1 binds to human epidermal growth factor receptor-2 (HER2) in tumors and then triggers the endocytosis of T-DM1 and release of payload. Therefore, endocytosis efficacy is considered as a critica...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Keying, Mei, Shengsheng, Gao, Xiangzheng, Peng, Shanshan, Zhan, Jinbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713712/
https://www.ncbi.nlm.nih.gov/pubmed/34992350
http://dx.doi.org/10.2147/DDDT.S344052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713712/
https://www.ncbi.nlm.nih.gov/pubmed/34992350
http://dx.doi.org/10.2147/DDDT.S344052

Ejemplares similares